Demet Özcan, Patricia Switten Nielsen, Jan Alsner, Mette Holck Nielsen, Else Maae, Marie Louise Holm Milo et al. Associations between tumor immune response and prognosis in node-negative breast cancer patients in the randomized DBCG HYPO trial. // BMC Cancer. – 2026. – DOI: 10.1186/s12885-026-15859-w. – URL: https://doi.org/10.1186/s12885-026-15859-w
Demet Özcan, Patricia Switten Nielsen, Jan Alsner, Mette Holck Nielsen, Else Maae, Marie Louise Holm Milo, Jens Overgaard, Birgitte Vrou Offersen, & Trine Tramm (2026). Associations between tumor immune response and prognosis in node-negative breast cancer patients in the randomized DBCG HYPO trial. BMC Cancer. https://doi.org/10.1186/s12885-026-15859-w
Demet Özcan, et al. “Associations between tumor immune response and prognosis in node-negative breast cancer patients in the randomized DBCG HYPO trial.” BMC Cancer, 2026. doi:10.1186/s12885-026-15859-w.
@article{zcan2026,
title = {Associations between tumor immune response and prognosis in node-negative breast cancer patients in the randomized DBCG HYPO trial},
author = {Özcan, Demet and Nielsen, Patricia Switten and Alsner, Jan and Nielsen, Mette Holck and Maae, Else and Milo, Marie Louise Holm and Overgaard, Jens and Offersen, Birgitte Vrou and Tramm, Trine},
journal = {BMC Cancer},
year = {2026},
doi = {10.1186/s12885-026-15859-w},
url = {https://doi.org/10.1186/s12885-026-15859-w}
}